Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Cancer Research|December 10, 2014
Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasisJelena Stanisavljevic, Jordina Loubat-Casanovas, Mercedes Herrera, et al.
Oncotarget|October 27, 2017
A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 studyAlberto Ocana, Marta Gil-Martin, Miguel Martín, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trialRoy S Herbst, Anne-Marie Maddox, Mace L Rothenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
NH(2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancerMiguel A Molina, Rosana Sáez, Elizabeth E Ramsey, et al.
Molecular Medicine (Cambridge, Mass.)|March 26, 2025
Involvement of microRNAs-449/FASN axis in response to trastuzumab therapy in HER2-positive breast cancerAna Lameirinhas, Sandra Torres-Ruiz, Iris Garrido-Cano, et al.
Oncotarget|July 16, 2014
High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patientsIsrael Cañadas, Alvaro Taus, Iria González, et al.
Cancer Genetics|May 8, 2012
Are ER+PR+ and ER+PR- breast tumors genetically different? A CGH array studyAlma Carracedo, Marta Salido, Josep M Corominas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2013
Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancerIsrael Cañadas, Federico Rojo, Álvaro Taus, et al.
Plos One|June 8, 2012
Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancerJulia Inglés-Esteve, Mònica Morales, Alba Dalmases, et al.
Cancer Medicine|January 12, 2024
Actionable mutational profiling in solid tumors using hybrid-capture-based next-generation sequencing in a real-world setting in SpainSandra Zazo, Sandra Pérez-Buira, Nerea Carvajal, et al.
Pageof 23